Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:603168'
s Days Payable Range Over the Past 10 Years
Min: 44.19 Med: 82.22 Max: 192.9
Current: 176.45
During the past 13 years, Zhejiang Shapuaisi Pharmaceutical Co's highest Days Payable was 192.90. The lowest was 44.19. And the median was 82.22.
SHSE:603168's Days Payable is ranked better than 80.47% of 927
companies
in the Drug Manufacturers industry
Industry Median: 90.38
vs SHSE:603168: 176.45
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Shapuaisi Pharmaceutical Co Days Payable Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Shapuaisi Pharmaceutical Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Shapuaisi Pharmaceutical Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Zhejiang Shapuaisi Pharmaceutical Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Zhejiang Shapuaisi Pharmaceutical Co's Days Payable falls into.
Zhejiang Shapuaisi Pharmaceutical Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168) has a Days Payable of 202.99 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Zhejiang Shapuaisi Pharmaceutical Co and its competitors. This is 147% above median its historical median of 82.22. Over the past decade, Zhejiang Shapuaisi Pharmaceutical Co's Days Payable has ranged from 44.19 to 192.90. According to the industry distribution chart, Zhejiang Shapuaisi Pharmaceutical Co ranks #181 out of 927 companies in the Drug Manufacturers industry, placing it in the top 19.5%.
Is Zhejiang Shapuaisi Pharmaceutical Co's Days Payable too high?
Zhejiang Shapuaisi Pharmaceutical Co's current Days Payable of 202.99 is 147% above median its 10-year median of 82.22. Over the past 10 years, this metric has ranged from a low of 44.19 to a high of 192.90. The Drug Manufacturers industry median Days Payable is 90.38. Zhejiang Shapuaisi Pharmaceutical Co's value of 202.99 is 124.6% above this industry median. Based on the distribution chart, Zhejiang Shapuaisi Pharmaceutical Co ranks #181 out of 927 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Zhejiang Shapuaisi Pharmaceutical Co has a GF Score™ of 37/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Shapuaisi Pharmaceutical Co's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Zhejiang Shapuaisi Pharmaceutical Co ranks #181 out of 927 companies for Days Payable. This places Zhejiang Shapuaisi Pharmaceutical Co in the top 20% of its industry — outperforming the majority of peers. The industry median Days Payable is 90.38. Zhejiang Shapuaisi Pharmaceutical Co's value of 202.99 is 124.6% above this benchmark. Historically, Zhejiang Shapuaisi Pharmaceutical Co's own Days Payable has ranged from 44.19 to 192.90 over the past decade. While the company's 10-year median is 82.22 vs. the industry median of 90.38, Zhejiang Shapuaisi Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.38, based on 927 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhejiang Shapuaisi Pharmaceutical Co's current Days Payable of 202.99 is 124.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Zhejiang Shapuaisi Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Shapuaisi Pharmaceutical Co's current Days Payable is 202.99, which is 147% above median its own 10-year median of 82.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Shapuaisi Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥8.79, compared to a current price of ¥5.02 — trading 42.9% below its estimated fair value. The current Days Payable is 202.99, which is 147% above median its 10-year median of 82.22 and 124.6% above the Drug Manufacturers industry median of 90.38. Zhejiang Shapuaisi Pharmaceutical Co's overall GF Score™ is 37/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168), the current Days Payable is 202.99 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168) Overvalued in 2026?
Based on GuruFocus' analysis, Zhejiang Shapuaisi Pharmaceutical Co stock appears to be undervalued.
The current stock price of ¥5.02 is trading 42.9% below its estimated GF Value™ of ¥8.79.
GuruFocus considers Zhejiang Shapuaisi Pharmaceutical Co to be Significantly Undervalued.
Key valuation signals for SHSE:603168:
Days Payable: 202.99 (147% above median its 10-year median of 82.22)
GF Value™: ¥8.79 vs. price of ¥5.02 (42.9% below fair value)
Industry Position: 124.6% above the Drug Manufacturers median (#181 of 927)
No single metric tells the full story. See the SHSE:603168 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhejiang Shapuaisi Pharmaceutical Co Business Description
Zhejiang Shapuaisi Pharmaceutical Co Ltd is a China based pharmaceutical company. It is engaged in drug research and development, production and operation. The product portfolio of the company includes oral solutions, eye drops, tablets, hard capsules, suppositories, granules, raw materials dosage forms such as medicines, rinsing agent and mixture, and others. The company operates pharmaceutical manufacturing companies, pharmaceutical sales company, pharmaceutical retail company and pharmaceutical research institute. The products offered by the company are sold in China and are also exported to the other countries.
37GF Score
Get the complete analysis for SHSE:603168
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603168 has been successfully added to your 
